Evaluation of FRET real-time PCR assay for rapid detection and differentiation of  species in returning travellers and migrants by unknown
BioMed CentralMalaria Journal
ssOpen AcceMethodology
Evaluation of FRET real-time PCR assay for rapid detection and 
differentiation of Plasmodium species in returning travellers and 
migrants
Innocent Safeukui*1,5, Pascal Millet1,2,3, Sébastien Boucher1, 
Laurence Melinard1, Frédéric Fregeville2, Marie-Catherine Receveur4, 
Thierry Pistone4, Pierre Fialon2, Philippe Vincendeau1,2, Hervé Fleury1 and 
Denis Malvy3,4
Address: 1Pôle de Biologie Moléculaire, CHU de Bordeaux, Hôpital Pellegrin, Place Amélie Raba Léon, 33076 Bordeaux Cedex, France, 
2Laboratoire de Parasitologie, CHU de Bordeaux, 1 rue Jean Burguet, 33071 Bordeaux Cedex France, 3Centre René Labusquière, Université Victor 
Segalen Bordeaux 2,146 rue Léo Saignat, 33076 Bordeaux Cedex, France, 4Travel clinic and Imported Diseases Units, Department of Internal 
Medicine, University Hospital Centre, 1 rueJean-Burguet, 33071 Bordeaux Cedex, France and 5Safeukui Noubissi Innocent, Institut Pasteur, Unité 
d'Immunologie Moléculaire des Parasites, URA CNRS 2581, 28 Rue du Dr Roux, 75075 Paris, France
Email: Innocent Safeukui* - safeukui@pasteur.fr; Pascal Millet - pascal.millet@u-bordeaux2.fr; Sébastien Boucher - sebastien.boucher@viro.u-
bordeaux2.fr; Laurence Melinard - melinardlaurence@hotmail.com; Frédéric Fregeville - frederic.fregeville@chu-bordeaux.fr; Marie-
Catherine Receveur - marie-catherine.receveur@chu-bordeaux.fr; Thierry Pistone - thierry.pistone@chu-bordeaux.fr; 
Pierre Fialon - pierre.fialon@chu-bordeaux.fr; Philippe Vincendeau - philippe.vincendeau@parasito.u-bordeaux2.fr; 
Hervé Fleury - herve.fleury@viro.u-bordeaux2.fr; Denis Malvy - denis.malvy@chu-bordeaux.fr
* Corresponding author    
Abstract
Background: A simple real-time PCR assay using one set of primer and probe for rapid, sensitive
and quantitative detection of Plasmodium species, with simultaneous differentiation of Plasmodium
falciparum from the three other Plasmodium species (Plasmodium vivax, Plasmodium ovale and
Plasmodium malariae) in febrile returning travellers and migrants was developed and evaluated.
Methods: Consensus primers were used to amplify a species-specific region of the multicopy 18S
rRNA gene, and fluorescence resonance energy transfer hybridization probes were used for
detection in a LightCycler platform (Roche). The anchor probe sequence was designed to be
perfect matches to the 18S rRNA gene of the fourth Plasmodium species, while the acceptor probe
sequence was designed for P. falciparum over a region containing one mismatched, which allowed
differentiation of the three other Plasmodium species. The performance characteristics of the real-
time PCR assay were compared with those of conventional PCR and microscopy-based diagnosis
from 119 individuals with a suspected clinical diagnostic of imported malaria.
Results: Blood samples with parasite densities less than 0.01% were all detected, and analytical
sensitivity was 0.5 parasite per PCR reaction. The melt curve means Tms (standard deviation) in
clinical isolates were 60.5°C (0.6°C) for P. falciparum infection and 64.6°C (1.8°C) for non-P.
falciparum species. These Tms values of the P. falciparum or non-P. falciparum species did not vary
with the geographic origin of the parasite. The real-time PCR results correlated with conventional
PCR using both genus-specific (Kappa coefficient: 0.95, 95% confidence interval: 0.9 – 1) or P.
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time assay was 100% sensitive and specific for differentiation of P. falciparum to non-P. falciparum
species, compared with conventional PCR or microscopy. The real-time PCR assay can also detect
individuals with mixed infections (P. falciparum and non-P. falciparum sp.) in the same sample.
Conclusion: This real-time PCR assay with melting curve analysis is rapid, and specific for the
detection and differentiation of P. falciparum to other Plasmodium species. The suitability for routine
use of this assay in clinical diagnostic laboratories is discussed.
Background
Plasmodium falciparum and Plasmodium vivax account for
the majority of malaria cases worldwide [1]. Plasmodium
falciparum is responsible for complications and death,
mainly in non-immune individuals. On the other hand,
P. vivax and Plasmodium ovale induce mild malaria symp-
toms restricted to fever with rare complications, while
Plasmodium malariae infections result in mild sympto-
matic malaria. Furthermore, P. vivax and P. ovale produce
dormant liver stages that may result in relapse of infection
months to years later, while P. malariae infections can per-
sist for decades, although dormant liver forms are not
thought to occur.
It is currently estimated that 50–80 million individuals
from industrialized countries visit malaria-endemic areas
each year and approximately 10,000–30,000 travellers
contract malaria [2], among which severe malaria
accounts for approximately 5% (range 1–38%) [3], with a
mortality rate ranging from 0.6% to 3.8% mainly result-
ing mostly from late and/or misdiagnosis, and delayed
treatment administration [4-8]. Because about 90% of
travellers who contract malaria will not become ill until
returning home, preventing malaria-associated morbidity
and mortality requires improved rapid and accurate labo-
ratory diagnostic tools detecting low parasitaemia and dif-
ferentiating febrile patients with P. falciparum from the
other Plasmodium species. Such diagnostic, performed at
the time of patient admission, will allow a prompt and
adequate treatment and follow-up [9].
Light microscopy of thick and thin Giemsa-stained blood
smears remains the gold standard for malaria diagnostic
[10]. However, even in expert hands (increasingly missed
in industrialized countries), microscopy demonstrated
limitations, mostly related to low sensitivity (detection
limit: 10–50 trophozoites/µl) and misdiagnosis [4,11-
15]. In some case, parasite morphology is damaged due to
exposition to prophylactic medication or auto-medica-
tion, making malaria biological diagnosis more difficult.
Alternative methods for laboratory diagnostic of malaria
have been developed, including fluorescence microscopy
of parasite nuclei stained with acridin orange and rapid
dipstick immunoassays. The advantages offered by these
methods, such as the fact that a result can be obtained
within half an hour by non-skilled technicians, are tem-
pered by three limitations reviewed by Moody et al [16]:
1) the dipstick tests do not improve sensitivity over micro-
scopy and the sensitivity decreases as parasitaemia falls
below 100 parasites/µl [17]; 2) false positives are
observed, particularly after treatment, as the parasite anti-
gens detected can remain in the circulation following par-
asite clearance, or in the presence of pneumococcal
meningitis infection [18]; and 3) many dipstick tests are
specific to P. falciparum infections.
A variety of PCR-based techniques have been developed
for the genus or species-specific diagnosis of malaria par-
asite infection [11,13,19-21]. While demonstrating
increased sensitivity and specificity, they remained
labour-intensive, time-consuming and prone to carry
more DNA contamination during manipulation of post-
amplification products. The recent advance of a real-time
quantitative PCR technique has proven usefulness in var-
ious applications, including parasite detection, species
differentiation, gene expression and regulation, and
allelic discrimination [22-30]. However, the large major-
ity of developed real-time PCR assays used many set of
primers and/or probes to analyse each sample, thus
increasing cost and reliability.
To date, one fluorescence resonance energy transfer
(FRET) real-time PCR assay using one set of primer and
probe [31], and two others real-time PCR methods using
one set of primer and SYBR green dye [26,32] for Plasmo-
dium sp. identification and species differentiation have
been evaluated. The principal limitation of these assays
was the lack of sensitivity of parasite detection: two to 30
parasites/µl of blood according to the study. Furthermore,
the real-time PCR approach using SYBR green dye did not
avoid the quantification of non-specific amplification
products [33]. Here, a real-time PCR assay using a single
set of primer and FRET hybridization probe for sensitive
and quantitative detection of Plasmodium species, with
simultaneous differentiation of P. falciparum from other
human Plasmodium species was developed and evaluated.
Results from the real-time PCR assay were compared to
conventional PCR methods and microscopy examination
of blood smears.Page 2 of 11
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Origin of the clinical specimens and DNA template 
preparation
A total of 119 blood samples were collected in EDTA tube
from travellers or migrants admitted to the Saint André
University Hospital in Bordeaux, with suspected clinical
malaria from years 2000 to 2006. Blood samples were col-
lected before the initiation of the antimalarial treatment.
One aliquot of each sample was used for routine biologi-
cal diagnostic in the Biology Laboratory and the other one
was stored at -80°C until use. DNA was extracted from
200 µl of blood using either the QIAamp DNA mini Kit
(QIAGEN) or using an automated DNA extraction
machine (MAGNA PURE LC, Roche Diagnostics, Indiana-
polis, Ind.) according to the manufacturer's instructions.
The samples were run blindly for real-time PCR and con-
ventional PCR assays.
Primer and probe design
The primers and probes were designed using the multi-
copy, stable and highly conserved [34] 18S rRNA gene sin-
gle-stranded sequences of Plasmodium species available
from GenBank (P. falciparum, accession number:
AL010278; P. vivax, accession number: U83877; P. ovale,
accession number: L48986 and P. malariae, accession
number: M54897). The primers and probes are summa-
rized in Table 1. Figure 1 shows their position and the
alignment results of the 18S rRNA gene single-stranded
sequences using the ClustalW multiple sequence align-
ment program (EMBL – European Bioinformatics Insti-
tute, Cambridge, UK). The sequences of the primers and
the anchor FRET hybridization probe were designed to be
perfect matches (i.e., 100% homologous) to the P. falci-
parum, P. vivax, P. ovale and P. malariae sequences. The
sequence of the acceptor FRET hybridization probe was
designed on the basis of one nucleotide mismatch differ-
ence that distinguish the 18S rRNA gene of the P. falci-
parum from those of the three other Plasmodium species.
To ensure proper hybridization of the probe to the target
sequence, oligonucleotides with a Tm at least 5°C higher
than the actual annealing/extension temperature were
chosen as probes. The 3' end of the anchor FRET hybridi-
zation probe was labelled with fluorescein isothiocyanate
(FITC) and the 5' end of the acceptor FRET hybridization
probe with LCRed705. Possible oligonucleotide dimers
formation and/or self-complementarity and the theoreti-
cal melting temperatures of primers and probes (Tms)
were calculated using Oligo programme version 4 (Light-
Cycler Probe Design Software, Roche). Oligonucleotide
primers and probes were obtained from Eurogentec and
Proligo, respectively. The P. falciparum-specific primers
were designed to amplify a 120-bp region from the cyto-
chrome c oxidase subunit 1 (cox1) mitochondrial gene.
FRET real-time PCR
Amplification and detection
Purified DNA templates were amplified in a LightCycler
analytical PCR system (version 6.0, Roche Diagnostics,
Indianapolis, Ind.). The real-time PCR was performed
using the "LightCycler DNA Amplification Kit Hybridiza-
tion Probes" (Roche Diagnostics, Mannheim, Germany),
according to the manufacturer's instructions. The reaction
was realized in a final volume of 20 µl in each capillary
tube containing 3.0 mM MgCl2, 0.5 µM of each primer,
0.25 µM of acceptor probe, 0.20 µM of anchor probe, 2 µl
of 10× LightCycler-FastStart DNA master hybridization
probe mixture, and 10 µl of extracted DNA. After a short
centrifugation (700 g for 10 s), the sealed capillaries were
placed into the LightCycler. The PCR program ran as fol-
lows: (i) 8 min at 95°C for enzyme activation and DNA
denaturation, and (ii) 45 PCR amplification cycles con-
sisting of 95°C for 15 s, 57°C for 10 s, and 72°C for 8 s.
The temperature transition rate was 20°C/s in the dena-
turation and annealing steps and 5°C/s in the polymeri-
zation step. In the final cycle, the melting curve was
obtained by initially heating to 95°C for 1.50 mn and
subsequently cooling the samples to 45°C for 30 s. A final
heating step to 95°C was realized with a controlled tem-
perature transition rate of 0.4°C/s. The resulting fluores-
cence was recorded starting at the final 95°C heating step
using the parameter "continuous mode" and the F3/F1
channel.
Table 1: Primers and probes selected for PCR of Plasmodium 18S rRNA and cox1 genes
Sequence Target gene
Primers Genus specific Forward 5'-GTTTAAGGCAACAACAGGT-3' 18S rRNA
Reverse 5'-CAATAATCTATCCCCATCACGA-3'
P. falciparum specific Forward 5-TTACATCAGGAATGTTATTGC-3 cox1
Reverse 5-ATATTGGATCTCCTGCAAAT-3
Probes Sensor 5'-ACTCGTTATACATATCAGTGTAGCACGC (FLU)-3' 18S rRNA
5'-(Red 705)
Anchor GCAGCCTAGTTCATCTAAGGACATCACAG (P)- 3'
Amplicon length: P. ovale: 198 pb (1662 – 1859); P. vivax: 178 pb (1435 – 1612); P. malariae: 207 pb (1873 – 2079) and P. falciparum: 190 pb (1035 – 
1225). The nucleotide positions are those reported in GenBankPage 3 of 11
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The presence of an amplification or quantification curve
for the LC705 signal captured in the F3 channel of the
LightCycler, in conjunction with a melt curve with a melt-
ing temperature (Tm) of about 60.0°C, was considered a
positive result for the P. falciparum; the presence of a quan-
tification curve with a corresponding melt curve with a Tm
of about 65.0°C was considered a negative result for the
P. falciparum species and positive for at least one of the
other three species. The absence of a quantification curve
was considered as negative for the fourth species.
Analytical sensitivity
The minimum detection limit of the Plasmodium FRET
assay was evaluated by use of a 10-fold dilution series of
DNA (5000 to 0.25 parasites in a 20 µl PCR reaction vol-
ume) extract from blood samples recovered from four
patients infected with P. falciparum (parasitaemia: 0.01%
in Giemsa-stained thin blood smear). Each experiment
included one reaction mixture without DNA as a negative
control, and each specimen was run in duplicate for real-
time PCR assay in parallel to conventional PCR.
Analytical specificity
To estimate the analytical specificity of the Plasmodium
FRET assay, DNA was obtained and managed from Euro-
pean individuals who have never travelled to malaria
endemic area (n = 10) or patients diagnosed with other
infectious microorganisms (Toxoplasma gondii, Leishmania
infantum, Pneumocistis carinii, Loa loa and Trypanosoma bru-
cei gambiense, n = 2 samples for each microorganism).
Clinical specimen's sensitivity and specificity
The clinical sensitivity and specificity of the Plasmodium
FRET assay for detecting and identifying malaria parasite
species were calculated on 119 whole-blood samples,
using conventional Giemsa-stained blood smear as the
reference gold standard.
Primer and fluorescence probe positions selected for FRET PCR of Plasmodium 18S rRNA geneFigure 1
Primer and fluorescence probe positions selected for FRET PCR of Plasmodium 18S rRNA gene. Sequences of 
forward (underline left panel) and reverse (underline right panel) primers were aligned with the corresponding target 
sequences. FRET probes for detection of parasite (blue and red for anchor and acceptor FRET hybridization probes, respec-
tively). Acceptor FRET hybridization probe was designed on the basis of one nucleotide mismatch difference (shown in pink 
colour) that distinguish 18S rRNA gene of P. falciparum (GenBank Accession number: AL010278) from that of the P. vivax (Gen-
Bank Accession number: U83877) or P. ovale (GenBank Accession number: L48986) or P. malariae (GenBank Accession 
number: M54897).Page 4 of 11
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Two conventional PCR procedures were conducted: one
with Plasmodium genus-specific primers (the same primers
used in real-time PCR assay) and another with P. falci-
parum-specific primers. The PCR reaction was realized in a
final volume of 50 µl containing the following reagent
mixture: 1× of PCR buffer 10× (500 mM KCl, 100 mM
Tris-HCl [pH 8.3], 20 mM MgCl2), 5 mM concentration of
MgCl2, 0.5 µM each oligonucleotide primer, 200 µM
deoxynucleoside triphosphate (Eurobio), and 0.02 unit
Taq DNA polymerase (Eurobio). For each PCR tube, 40 µl
PCR reagent mixture and 10 µl DNA were used. The reac-
tions were carried out under the following conditions: (i)
initial denaturation at 94°C for 3 mn, (ii) 35 cycles of:
denaturation at 94°C for 30 s, annealing at 58.5°C for 30
s, extension at 72°C for 8 s, and (iii) final extension at
72°C for 5 min. Each experiment included one positive
control (consisting of P. falciparum genomic DNA from
positive blood samples) and one negative control (con-
sisting of sterile double-distilled water). Amplified PCR
products were detected by running 14 µl of the PCR mix-
ture on a standard 1.5% agarose gel stained with a 1.0 µg/
ml ethidium bromide solution and visualized under UV
light.
Statistical analysis
The 95% confidence intervals of proportions were calcu-
lated using the exact binomial test. Concordance between
the results of real-time PCR and either conventional PCR
assay or microscopy was analysed using the Kappa test
[35]. All statistical analyses were performed using the SAS
software (version 8.2).
Results
Detection of Plasmodium genus and species 
differentiation
DNA extracted from blood samples recovered from seven
febrile patients harbouring Plasmodium species (Giemsa-
stained blood smear positive) was used as a template for
this assay: patients presenting with single species infec-
tions diagnosed by microscopical examination (two
patients with red blood cells harbouring P. falciparum or
P. vivax, and one with P. ovale or P. malariae) and one
patient with red blood cells harbouring both P. falciparum
and P. ovale. Typical amplification plots (change in fluo-
rescent signal versus cycle numbers) with a Ct varying
from 24.8 to 31.8 were obtained. Conventional PCR with
genus-specific primers (the same primers used for real-
time PCR) and DNA sequence analysis confirmed the spe-
cific amplification of the 18S rRNA gene of Plasmodium
species fragment. The FRET real-time PCR assay data
allowed differentiating P. falciparum from the other three
Plasmodium species. Mixed parasitism (P. falciparum plus
non-P. falciparum) were identified by the presence of the
two peaks simultaneously (Figure 2). The melting curve
means Tms (standard deviation) were 61.0 (0.8)°C for P.
falciparum (means of three patients, two harbouring P. fal-
ciparum only and the other with two Plasmodium species)
and 67.0 (0.7)°C for the three other species (means of five
individuals infected, four harbouring non-P. falciparum
only and the other one mixed infection).
Analytical sensitivity and specificity
The sensitivity, inter- and intra-assay variabilities for four
independent experiments are shown in Figure 3A. Positive
signals (Ct values) were found for all dilutions except for
0.25 parasite per reaction. A detection limit of 0.5 P. falci-
parum per PCR volume was achievable. The Ct mean val-
ues (standard deviations), ranging from 27.9 (2.0) for
5000 parasites per PCR volume to 42.6 (0.9) for 0.5 para-
site per PCR volume. Amplification efficiency of real-time
PCR reaction varied between 87 to 98% according to
experiment (Figure 3B). A significant coefficient of corre-
lation was found for the mean Ct values and P. falciparum
concentration (r = -0.98) (Figure 3B). These DNA samples
diluted were also amplified by conventional PCR with
genus-specific primers and followed by electrophoresis
and ethidium bromide staining (Figure 3C). The limit of
detection was five parasites per PCR volume (Figure 3C).
The conventional PCR assay was ten times less sensitive
than the FRET real-time PCR assay. No PCR amplification
by either real-time PCR, or conventional PCR with genus-
specific primers was observed with any DNA samples
obtained from European individuals who have never
travel to malaria endemic area or patients infected with T.
gondii, L. infantum, P. carinii, L. loa filaria or T. brucei gam-
biense.
Clinical specimen sensitivity and specificity
One hundred and nineteen febrile patients with a sus-
pected clinical diagnosis of imported malaria were
included in this study. Asexual parasitaemia means [95%
confidence interval or CI95%] at the inclusion was 0.7%
[0.3–1.2] (Giemsa-stained blood smears microscopic
examination). Two patients were gametocytaemic at day
0, among which one harboured only gametocytes without
asexual stages. Thirty-eight, 34 and three patients return-
ing from Central (Gabon, Republic of Central Africa,
Congo and Cameroon), Western (Benin, Burkina Faso,
Ivory Cost, Guinea, Senegal and Togo) and Eastern
(Kenya and Mozambique) African countries, respectively.
Other patients travelled in Madagascar (n = 4), French
Guyana (n = 2), Comores (n = 1) and Thailand (n = 1).
The geographical origin of parasites was not recorded for
36 patients.
Melting curve temperatures (Tms) of P. falciparum were
defined as Tms of DNA samples that were positive by 18S
real-time PCR with only one melting curve and positive by
conventional PCR using both genus- and P. falciparum-spe-Page 5 of 11
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defined as Tms of DNA samples that were > than Tm val-
ues of P. falciparum, positive both by 18S real-time PCR
with only one melt in a curve and conventional PCR using
genus-specific primers and, negative by conventional PCR
using P. falciparum-specific primers. According to these
definitions, we found that the melt curve means Tms
(standard deviation) in clinical isolates were 60.5°C
(0.6°C) for P. falciparum DNA amplicons and 64.6°C
(1.8°C) for non-P. falciparum sp DNA amplicons. These
results were closely related to melting temperature of 60.0
and 65.0°C for P. falciparum and non-P. falciparum sp
respectively, that were estimated during primer and probe
design using Oligo 4.0 software (LightCycler Probe
Design Software, Roche). Tms of the P. falciparum or non-
P. falciparum species were similar between geographic ori-
gin of parasite (Figure 4).
Real-time PCR and conventional PCR assays
The results shown in Table 2 represent the comparison
between 18S real-time PCR and conventional PCR assays.
Ninety one out of 119 DNA samples (76.5%) were posi-
tive by both the 18S screening real-time PCR and conven-
tional PCR using genus-specific primers, whereas 26
samples were negative by both methods, giving a concord-
ance rate of 98.3% (CI95%: 89.3 – 107.6) between real-
Melting curves of amplicons post real-time PCR of DNA extracted from three different blood samples with known P. falci-parum, non-P. falciparum (P. ovale) and mixed Plasmodium sp. (P. falciparum + P. oval )Fig re 2
Melting curves of amplicons post real-time PCR of DNA extracted from three different blood samples with 
known P. falciparum, non-P. falciparum (P. ovale) and mixed Plasmodium sp. (P. falciparum + P. ovale). The Tms of 
the P. falciparum were distinctively lower than that of P. ovale. Negative control included reaction mixture with water.
Negative control
P. falciparum
P. falciparum + P. ovale
P. ovalePage 6 of 11
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cific primers (Kappa coefficient: 0.95, CI95%: 0.9 – 1). Two
(1.7%) DNA samples positive by real-time PCR assay were
negative by conventional PCR assay using genus-specific
test (Table 2). Seventy one out of 119 DNA samples
(59.7%) were positive by both the 18S real-time PCR and
conventional PCR using P. falciparum-specific primers,
whereas 26 samples were negative by both methods, giv-
ing a concordance rate of 96.6% (CI95%: 87.6 – 105.6)
between real-time PCR assay and conventional PCR using
genus-specific primers (Kappa coefficient: 0.91, CI95%: 0.8
– 1). Four (3.4%) DNA samples identified as P. falciparum
by real-time PCR assay were negative by conventional
PCR assay using P. falciparum-specific primers (Table 2).
Real-time PCR and microscopy
Eighty six out of 119 DNA samples (72.3%) were positive
by both the real-time PCR and microscopy, whereas 26
Sensitivity, inter- and intra-assay variabilities of P. falciparum DNA quantificationFigure 3
Sensitivity, inter- and intra-assay variabilities of P. falciparum DNA quantification. (A) Results obtained from four 
independent tests in duplicate by real-time PCR assay using FRET. (B) Linearity of FRET assay PCR is shown using serially 
diluted P. falciparum DNA (5000 to 0.25 parasites per reaction, one representative experiment). Amplification efficiency (AE) is 
calculated based on the slope of the standard curves using the formula: E = 101/-s-1, where E(100) is the % efficiency and s is the 
slope of the standard cure. (C) Amplification of serially diluted P. falciparum DNA (5000 to 5 parasites per PCR reaction) by 
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ance rate of 94.1% (CI95%: 85.1 – 103.1) between micros-
copy and real-time PCR for detection of any Plasmodium
species (Table 3). A full agreement for Plasmodium sp.
detection and species differentiation between both assays
was found (Kappa coefficient: 0.70, CI95%: 0.6 – 0.8).
Seven patients identified with Giemsa-stained blood
smear as negative were positive with real-time PCR (five as
P. falciparum infection and two as non-P. falciparum spe-
cies). Eight DNA samples with undetermined species by
microscopy were identified as P. falciparum by the real-
time PCR (Table 3). These results were confirmed by con-
ventional PCR assays using both genus- and P. falciparum-
specific primers. The real-time PCR was able to detect
mixed infection (P. falciparum + non-P. falciparum spe-
cies). Two patient samples positive for P. ovale (Giemsa-
stained films) were recorded as samples harbouring P. fal-
ciparum and non-P. falciparum species with real-time PCR
assay. One patient which microscopic result was mixed
infection (P. falciparum and P. vivax, 2.6% and < 0.01% of
parasitaemia, respectively) was also identified as mixed
infection (P. falciparum + non-P. falciparum sp.) with real-
time PCR assay (Table 3). However, three patients with
Giemsa-stained films positive for mixed infection (P. fal-
ciparum and P. malariae) were mono-infection with real-
time PCR assay (2 patients with P. falciparum and one with
non-P. falciparum sp.) (Table 3).
Discussion
A real-time PCR method using the FRET system for detec-
tion of malaria parasites, with simultaneous differentia-
tion of the most threatening parasite P. falciparum from
the three other Plasmodium species (P. vivax, P. ovale and P.
malariae) was described. In order to increase the sensitivity
Amplicon melting temperature plots (Tms) of P. falciparum and non-P. falciparum sp. according to the geographic origin of infec-tionFigure 4
Amplicon melting temperature plots (Tms) of P. falciparum and non-P. falciparum sp. according to the geo-
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18S (small subunit) rRNA gene was targeted, as this gene
contains multiple copies dispersed throughout the Plas-
modium genome [36]. The real-time PCR results were com-
pared with those of conventional PCR and microscopy.
The proposed protocol was performed in 90 minutes,
including 30 minutes for DNA extraction, 15 minutes for
mix preparation, and 45 minutes for amplification and
results interpretation. In clinical isolates obtained from
returned travellers, an equivalent concordance rate
between real-time PCR assay and conventional PCR (≥
97%) or microscopic (94%) was found. The specificity to
detect Plasmodium sp. was 100% and the real-time PCR
assay was able to detect parasitaemia less than 0.01%
(microscopy examination). The proposed PCR method
demonstrates a higher sensitivity to identify cryptic
malaria infections. Seven febrile patients with negative
Giemsa-stained films were positive with real-time PCR
method. The analytical real-time PCR assay threshold was
0.5 compared to five parasites per PCR reaction with con-
ventional PCR assay using genus-specific primers (the
same primer used for real-time PCR assay). This sensitivity
is more important than that was previously obtained by
Swan and colleagues using similar approach [31], and cor-
respond favourably to other published methods, specifi-
cally real-time PCR assays using TaqMan probes
[23,25,27,37]. This high sensitivity is very important in
term of biological diagnostic of imported malaria, as
many returning travellers and migrants, sometimes under
prophylactic medication or auto-medication, display
febrile symptoms with very low-grade parasitaemia. In
some case, parasite morphology is damaged due to expo-
sition to prophylactic medication or auto-medication,
making malaria biological diagnosis using microscopy
more difficult.
The set of DNA primer and probe proposed in this study
demonstrated a high specificity to differentiate P. falci-
parum from the three other Plasmodium species (P. vivax, P.
malariae and P. ovale), based on the melting curve.
Monoinfections were systematically identified, and real-
time PCR has been even more effective than microscopy
examination, identifying undetermined parasites, identi-
fied as Plasmodium sp. by microscopist due to the lack of
specific form of parasites or morphological damages often
resulting from previous or current antimalarial treatment.
The real-time PCR assay was able to identify mixed infec-
tion (P. falciparum and non-P. falciparum sp.) and individ-
ual harbouring only gametocytes or gametocytes and
asexual stages from different malaria Plasmodium species.
Two patients who Giemsa-stained films were positive for
Table 2: Detection of Plasmodium DNA by real-time and conventional PCR assays in patients at day of inclusion
Conventional PCR, no. of patients
Genus-specific primers P. falciparum-specific primers
POS(a) NEG(b) POS(a) NEG(b)
Real-Time PCR P. falciparum 71 1 68 4
Non-P. falciparum sp. 17 1 0 18
Mixed Plasmodium sp.(c) 3 0 3 0
NEG(b) 0 26 0 26
(a)POS, posiive; (b)NEG, negative; (c)Mixed Plasmodium sp, P. falciparum + non-P. falciparum sp.
Table 3: Detection of Plasmodium species by microscopy and real-time PCR in patients at day of inclusion
Real-time PCR, no. of patients
POS(a) NEG(b)
P. falciparum non-P. falciparum sp Mixed Plasmodium sp.(c)
Microscopy P. falciparum 54 0 0 0
P. ovale 2 7 2 0
P. malariae 0 2 0 0
P. vivax 1 6 0 0
Plasmodium sp 8 0 0 0
Mixed infection 2 1 1 0
NEG(b) 5 2 0 26
(a)POS, positive; (b)NEG, negative; (c)Mixed Plasmodium sp, P. falciparum + non-P. falciparum sp.Page 9 of 11
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PCR assay. The validity of these results was supported by
the clear visualization of two separate fluorescence peaks
at different melting temperatures (59.7°C and 66.9°C,
59.5°C and 64.9°C, for the two assays), which corre-
spond to the melting curve Tms of P. falciparum (60.5 ±
0.6°C) and non-P. falciparum sp. (64.6 ± 1.8°C). The
detection of P. falciparum plus P. malariae mixed infection
was not resolved. Three patients with mixed infection by
microscopy (P. falciparum and P. malariae with parasitae-
mia density of P. malariae < 0.01%) were identified as P.
falciparum mono-infection (n = 2) or non-P. falciparum sp.
mono-infection (n = 1) with real-time PCR assay. This dis-
crepancy was also observed in experimental mixed infec-
tion with P. falciparum and P. malariae. The low number of
included patients harbouring mixed infection make that
more experiments need to be conducted in order to pre-
cise detection limit of parasites in the case of mixed infec-
tions. Precise identification of the presence of P.
falciparum associated or not with other Plasmodium species
is a critical issue for patient care and treatment outcome,
since i) P. falciparum infections are potentially fatal and ii)
drug resistance occur at a high level compared to other
species.
Geographically diverse malaria isolates obtained from
returning febrile travellers and migrants were analysed to
ensure that the assay would reliably differentiate P. falci-
parum from the three other species despite the parasite ori-
gin. The result indicates that the single base pair
mismatched which allowed differentiation of P. falci-
parum to the three other species is well conserved between
geographic regions of parasite which was evaluated. Single
base differences theoretically may also exist between
strains within a species from different geographic regions,
but our results indicate that no variance was found among
individual isolates. Additional specimens from other
regions around the world would be required to confirm
these observations.
Recently, Plasmodium knowlesi, a species that has morpho-
logical similarities with P. malariae, has been identified as
a human pathogen in patients from Malaysia [38].
Sequence analysis indicates that this species may also be
amplified by using the set of primer and probe proposed
in this study, and the expected Tm will be similar to that
of non-P. falciparum species. Further confirmations are
needed by testing P. knowlesi specimens with this real-time
PCR method.
Conclusion
A rapid, FRET real-time PCR assay using one set of primer
and probe for the diagnosis of Plasmodium sp. in febrile
returning travellers and migrants was described. An
important advantage of this approach is the higher sensi-
tivity and specificity for the detection of Plasmodium sp.
and to differentiate P. falciparum from the three other
malaria parasite species (P. vivax, P. malariae and P. ovale),
based on the melting. Concurrently to microscopic exam-
ination, such results can be used to ensure rapid treatment
administration and proper follow-up of the malaria
attacks by the practitioner. Except for P. falciparum and P.
malariae mixed infection, the ability to provide accurate
species identification in the same sample used for detec-
tion of the parasite is also a greatest attribute of this
method. The proposed protocol is performed through
automated extraction, amplification and interpretation
allowing access to any laboratory technician without spe-
cific knowledge in the field of malaria. Although the rela-
tively high cost of real-time PCR technology may preclude
its use in resource-poor clinics, its performance character-
istics, combined with its rapid results, suggest that it may
be a useful diagnostic adjunct in industrialized countries.
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